This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Mettler-Toledo (MTD) Q2 Earnings Top Estimates, Sales Fall Y/Y
by Zacks Equity Research
Mettler-Toledo's (MTD) second-quarter results benefit from strength in the Laboratory segment. However, sluggish market demand in China acts as a headwind.
Mettler-Toledo (MTD) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Mettler-Toledo (MTD) delivered earnings and revenue surprises of 7.22% and 2.48%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
What's in the Offing for Mettler-Toledo's (MTD) Q2 Earnings?
by Zacks Equity Research
Mettler-Toledo's (MTD) second-quarter results are likely to reflect weak momentum across the Industrial, Laboratory and Food Retail segments.
Countdown to Mettler-Toledo (MTD) Q2 Earnings: Wall Street Forecasts for Key Metrics
by Zacks Equity Research
Besides Wall Street's top -and-bottom-line estimates for Mettler-Toledo (MTD), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2024.
Earnings Preview: Mettler-Toledo (MTD) Q2 Earnings Expected to Decline
by Zacks Equity Research
Mettler-Toledo (MTD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Beat the Market Like Zacks: Goldman Sachs, Micron, Amgen in Focus
by Abhinab Dasgupta
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
Here's Why Mettler-Toledo (MTD) is a Strong Momentum Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Beat the Market the Zacks Way: EverQuote, Micron, Amgen in Focus
by Abhinab Dasgupta
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.
Zacks Industry Outlook Highlights Mettler-Toledo and Bruker
by Zacks Equity Research
Mettler-Toledo and Bruker have been highlighted in this Industry Outlook article.
2 Instruments Stocks to Watch From a Prospering Industry
by Aniruddha Ganguly
The Zacks Instruments - Scientific industry participants like Mettler-Toledo (MTD) and Bruker (BRKR) are gaining from strong life science, pharmaceutical and academic end-market demand despite the challenging macroeconomic environment.
Don't Overlook Mettler-Toledo (MTD) International Revenue Trends While Assessing the Stock
by Zacks Equity Research
Explore how Mettler-Toledo's (MTD) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
Beat the Market the Zacks Way: Micron, Freshpet, Colgate-Palmolive in Focus
by Abhinab Dasgupta
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
Mettler-Toledo (MTD) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
The headline numbers for Mettler-Toledo (MTD) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Mettler-Toledo (MTD) Q1 Earnings Top Estimates, Sales Fall Y/Y
by Zacks Equity Research
Mettler-Toledo's (MTD) first-quarter 2024 results reflect the impacts of weak momentum in the Food Retail segment and challenging market conditions in China.
Mettler-Toledo (MTD) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Mettler-Toledo (MTD) delivered earnings and revenue surprises of 16.82% and 5.14%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Harvard Bioscience (HBIO) Q1 Earnings Match Estimates
by Zacks Equity Research
Harvard Bioscience (HBIO) delivered earnings and revenue surprises of 0% and 4.92%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
What's in the Offing for Mettler-Toledo's (MTD) Q1 Earnings?
by Zacks Equity Research
Mettler-Toledo's (MTD) first-quarter performance is likely to reflect the adverse impacts of macroeconomic headwinds, and weak momentum across the Industrial and Laboratory segments.
Exploring Analyst Estimates for Mettler-Toledo (MTD) Q1 Earnings, Beyond Revenue and EPS
by Zacks Equity Research
Beyond analysts' top -and-bottom-line estimates for Mettler-Toledo (MTD), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2024.
Analysts Estimate Mettler-Toledo (MTD) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Mettler-Toledo (MTD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Is Bruker (BRKR) Up 15.7% Since Last Earnings Report?
by Zacks Equity Research
Bruker (BRKR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks Industry Outlook Highlights Mettler-Toledo and Bruker
by Zacks Equity Research
Mettler-Toledo and Bruker have been highlighted in this Industry Outlook article.
2 Instruments Stocks to Buy From a Prospering Industry
by Aniruddha Ganguly
The Zacks Instruments - Scientific industry participants like Mettler-Toledo (MTD) and Bruker (BRKR) are gaining from strong life science, pharmaceutical and academic end-market demand despite the challenging macroeconomic environment.
Mettler-Toledo (MTD) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
The headline numbers for Mettler-Toledo (MTD) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Mettler-Toledo (MTD) Q4 Earnings & Sales Miss, Fall Y/Y
by Zacks Equity Research
Mettler-Toledo's (MTD) fourth-quarter 2023 results reflect weak momentum in the Industrial and Laboratory segments. Shipment delays from a new external European logistics provider, was a major concern.
What's in the Offing for Mettler-Toledo's (MTD) Q4 Earnings?
by Zacks Equity Research
Mettler-Toledo's (MTD) fourth-quarter results are likely to reflect weakness in the overall demand environment, particularly in the Laboratory and Industrial segments.